Operating Lease, Liability in USD of IGC Pharma, Inc. from Q1 2020 to Q1 2025

Taxonomy & unit: us-gaap: USD
Description: Present value of lessee's discounted obligation for lease payments from operating lease.
Summary: IGC Pharma, Inc. quarterly Operating Lease, Liability history and change rate from Q1 2020 to Q1 2025.
IGC Pharma, Inc. Operating Lease, Liability for the quarter ending March 31, 2025 was $103K, a 50.5% decline year-over-year.

Operating Lease, Liability, Quarterly (USD)

Operating Lease, Liability, YoY Quarterly Change (%)

IGC Pharma, Inc. Quarterly Operating Lease, Liability (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q1 2025	$103K	-$105K	-50.5%	Mar 31, 2025	10-K	2025-06-27
Q1 2024	$208K	-$132K	-38.8%	Mar 31, 2024	10-K	2025-06-27
Q1 2023	$340K	-$124K	-26.7%	Mar 31, 2023	10-K	2024-06-24
Q4 2022	$371K	-$123K	-24.9%	Dec 31, 2022	10-Q	2023-02-14
Q3 2022	$403K	-$118K	-22.6%	Sep 30, 2022	10-Q	2022-11-01
Q2 2022	$434K	-$113K	-20.7%	Jun 30, 2022	10-Q	2022-08-05
Q1 2022	$464K	-$31K	-6.26%	Mar 31, 2022	10-K	2023-07-07
Q4 2021	$494K	-$22K	-4.26%	Dec 31, 2021	10-Q	2022-02-10
Q3 2021	$521K	-$15K	-2.8%	Sep 30, 2021	10-Q	2021-10-29
Q2 2021	$547K	-$8K	-1.44%	Jun 30, 2021	10-Q	2021-08-11
Q1 2021	$495K	-$79K	-13.8%	Mar 31, 2021	10-K	2022-06-23
Q4 2020	$516K			Dec 31, 2020	10-Q	2021-02-16
Q3 2020	$536K			Sep 30, 2020	10-Q	2020-11-20
Q2 2020	$555K			Jun 30, 2020	10-Q	2020-08-19
Q1 2020	$574K			Mar 31, 2020	10-K	2021-06-14

* An asterisk sign (*) next to the value indicates that the value is likely invalid.